Navigate - Improving Survival and Quality of Life in Vulnerable Lung Cancer Patients

Half of patients with lung cancer face a limited life span of one-year survival, which is characterized by severe physical and psychological symptoms. Differences in stage, comorbidity but also treatment may explain a large proportion of the social inequality in lung cancer survival. Some vulnerable patients may not receive first line treatment as planned either due to poor performance status or if they are not able to adhere to treatment appointments. Knowing how to navigate the health system may be a barrier preventing vulnerable patients in receiving optimal treatment. The primary aim of th

Trial Details

NCT ID
NCT05053997
Phase
NA
Sponsor
Zealand University Hospital
Status
RECRUITING
Cancer Type
Lung Cancer
Interventions
  • NAVIGATE
Locations (sample)
  • Aalborg, Denmark|57.048,9.9187
  • Herning, Denmark|56.13615,8.97662
  • Odense, Denmark|55.39594,10.38831
  • Roskilde, Denmark|55.64152,12.08035
  • Sønderborg, Denmark|54.90896,9.78917

Key Eligibility Criteria

  • Age ≥ 18 years of age
  • Diagnosed with NSCLC at all stages regardless of treatment intension at the participating departments
  • Performance status ≤ 2
  • Vulnerable according to pre-defined criteria

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lung Cancer Trials on Trialify →